The U.S. Homeland Security Department’s inspector general said on Friday he was investigating possible abuse of authority in a case that triggered a lawsuit against the department by Twitter.
I spend most of the year laser-focused on games. But next week, I’m going to expand my horizons beyond games to the entire tech industry. I’ll be attending CES 2017, the big tech trade show next week in Las Vegas. I’ve lost count how many times I’ve made it to this show, but I still […]
During a political season in which fact checking became a central part of the cultural conversation, somehow facts seemed to matter less than ever to the outcome. This was one of the more puzzling contradictions of this tumultuous election season for me, and honestly, a bit dispiriting as a journalist. So much effort was mustered by […]
Screenwriters do this. So do producers. Now it’s your turn.
(By Jonathan Stempel, Reuters) – A founder of Run-DMC on Thursday filed a lawsuit accusing Amazon and Wal-Mart of selling a wide variety of clothing and accessories bearing the pioneering rap group’s name without permission. Darryl McDaniels, the owner of Run-DMC Brand LLC, the plaintiff in the lawsuit, is seeking at least $50 million of damages […]
When it came to public offerings by tech companies, 2016 emerged like a corpse and only exhibited the faintest of heartbeats by the end. Still, it’s worth re-writing the line that we have all written for the last two years: Next year could be much better! And this time, that could actually turn out to […]
(Reuters) — Downtown Havana resident Margarita Marquez says she received a special Christmas gift this year: web access at home, a rarity in a country with one of the lowest internet penetration rates in the world. Marquez, a 67-year-old retired university professor, was among those selected by the government two weeks ago to participate in a […]
Microsoft kicked off the first ever Global Startup Roadshow last June. Fifteen participating companies were chosen from a list of over 500 startups that achieved global success and aim to introduce their products to the U.S. market. CEOs of the selected startups spent a…
When someone wants to look for a specific user on Twitter, it’s likely that the first thought is to use the network’s search tool. There, one can search by name, username, or by content. But sometimes, this just isn’t enough, making searches too time consuming…
A Baltimore start-up tackles blindness with new innovative treatments.
Warby Parker isn’t the only start-up disrupting the vision space. GrayBug, a company that recently won the Invest Maryland Challenge in Baltimore, Maryland, is revolutionizing drug delivery and treatments for the eye.
GrayBug started after three professors at the Wilmer Eye Institute at Johns Hopkins University–Justin Hanes, Peter Compochiaro, and Peter McDonnell–developed two treatments to help patients who suffer from age-related macular degeneration. The three founders determined that the fastest way to get their innovations to the public was to start a company.
Age-related macular degeneration is a leading cause of blindness in adults 65 and over, with over 20 million cases in the U.S. and Europe. GrayBug estimates that market is worth around $4 billion worldwide. The typical treatment includes receiving injections in the eye every one to two months. GrayBug claims its sustained-release drugs may reduce the number of injections needed to just twice per year–a potential boon for the tens of million patients who describe the experience as disturbing and painful. Other treatments for blinding ocular diseases, such as glaucoma, are in the works.
So far, the company has three full-time employees and more than a dozen advisors. A GrayBug spokesperson declined to offer specifics about the company’s valuation or annual revenue, but says that Baltimore’s thriving start-up scene helped drive the company’s early success. Not only does GrayBug enjoy easy access to a number of prestigious universities and federal institutions, but the Maryland Biotechnology Center and BioMaryland have also extended support.
In recent years, Baltimore has become a thriving hub of health innovation. The state of Maryland ranked No. 2 for science and technology assets (behind Massachusetts), according to the Milken Institute. One of the foremost biotech companies, MedImmune, which is based in Baltimore, developed the FluMist nasal spray influenza vaccine. Other innovators include Zyngenia, a biotech company, and MedImmune’s venture capital arm, which invests in health start-ups.